ANI Pharmaceuticals | ANIP - Assets

Stock Price
79.57
Daily Change
0.93 1.18%
Monthly
7.43%
Yearly
13.96%
Q2 Forecast
76.96

ANI Pharmaceuticals reported $1.44B in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
AbbVie USD 133.96B 62M Dec/2025
ANI Pharmaceuticals USD 1.44B 32.22M Dec/2025
Assertio Holdings USD 319.77M 46M Sep/2025
Aurora Cannabis CAD 775.29M 18.43M Dec/2025
Canopy Growth CAD 1.11B 36.35M Dec/2025
Eli Lilly USD 112.48B 2.46B Dec/2025
Emergent BioSolutions USD 1.82B 69.9M Dec/2023
Heron Therapeutics USD 255.88M 6.93M Dec/2025
Hikma Pharmaceutical USD 5.67B 117M Dec/2025
Knight Therapeutics CAD 1.05B 2.28M Dec/2025
Nektar Therapeutics USD 280.41M 20.94M Dec/2025
Novartis USD 110.95B 3.66B Dec/2025
Omeros USD 200.57M 34.59M Jun/2025
Perrigo USD 8.54B 1.55B Dec/2025
Sun Pharmaceuticals INR 1.04T 116.06B Sep/2025
Teva Pharmaceutical Industries USD 40.75B 892M Dec/2025